Elaine Warburton CEO & Co-founder
elaine.warburton@quantumdx.com
An experienced Board Director with over 20 years’ experience in biotech
and healthcare management and an authority in bringing innovative
technologies into mainstream medicine.
Jonathan O’Halloran CSO & Co-founder
jonathan.ohalloran@quantumdx.com
Inventor of QMDx’s nucleic acid and sequencing technology with over 10
years in scientific research and biotechnology, clinical laboratories
and clinical management.
Paul Fitzpatrick, Non Executive Director
paul.fitzpatrick@quantumdx.com
US
Partner and Investor Relations. An experienced CEO with expertise in
series A and B fund raising and bringing medical devices to market.
Julian Warburton, Non Executive Director
julian.warburton@quantumdx.com
Finance. An experienced financier with expertise in Corporate Finance,
Banking and Treasury operations. Julian currently works at Intertek
Plc, a global company specialising in quality assurance accreditation
including medical device accreditation.
Professor John Burn MD FRCP FRCPCH FRCOG FMedSci
Professor Burn is acting as a medical and scientific advisor to the company, is head
of the Institute of Human Genetics at Newcastle University, a top rated
research centre, and an honorary consultant at the Newcastle Hospitals
NHS Foundation Trust where he was the director of regional genetic
services from 1989 to 2004. He has extensive experience as a government
advisor and broadcaster. He was a founder member of the UK Human
Genetics Commission and 2007 President of the European Society of Human
Genetics. Recent appointments include Chair of the Genetics Committee
of the National Institute of Health Research, Head of the new NIHR
Collaborative Group on Genetics in Healthcare and Lead Clinician for
NHS North East. In the latter role he will have responsibilty for
change management among the clinicians serving the 2.5 million people
of North East England.